769 related articles for article (PubMed ID: 15304389)
1. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Gumá M; Angulo A; Vilches C; Gómez-Lozano N; Malats N; López-Botet M
Blood; 2004 Dec; 104(12):3664-71. PubMed ID: 15304389
[TBL] [Abstract][Full Text] [Related]
2. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
4. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
Monsiváis-Urenda A; Noyola-Cherpitel D; Hernández-Salinas A; García-Sepúlveda C; Romo N; Baranda L; López-Botet M; González-Amaro R
Eur J Immunol; 2010 May; 40(5):1418-27. PubMed ID: 20201038
[TBL] [Abstract][Full Text] [Related]
5. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
[TBL] [Abstract][Full Text] [Related]
6. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
Ding Y; Sumitran S; Holgersson J
Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
Shilling HG; McQueen KL; Cheng NW; Shizuru JA; Negrin RS; Parham P
Blood; 2003 May; 101(9):3730-40. PubMed ID: 12511415
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes.
Zambello R; Falco M; Della Chiesa M; Trentin L; Carollo D; Castriconi R; Cannas G; Carlomagno S; Cabrelle A; Lamy T; Agostini C; Moretta A; Semenzato G; Vitale M
Blood; 2003 Sep; 102(5):1797-805. PubMed ID: 12750175
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M; Yamashita T; Fujii T; Nagamatsu T; Kozuma S; Taketani Y
J Reprod Immunol; 2006 Jun; 70(1-2):33-42. PubMed ID: 16488482
[TBL] [Abstract][Full Text] [Related]
10. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
11. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
12. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
[TBL] [Abstract][Full Text] [Related]
13. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
[TBL] [Abstract][Full Text] [Related]
14. NK cell receptors involved in the response to human cytomegalovirus infection.
Gumá M; Angulo A; López-Botet M
Curr Top Microbiol Immunol; 2006; 298():207-23. PubMed ID: 16323417
[TBL] [Abstract][Full Text] [Related]
15. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A; Vilches C; Angulo A; López-Botet M
Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
[TBL] [Abstract][Full Text] [Related]
16. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant.
Lin Chua H; Brahmi Z
Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268
[TBL] [Abstract][Full Text] [Related]
17. [CD94/NKG2A--a kind of inhibitory receptor belonging to C-type lectin superfamily].
Wang Y; Zhu LP; Zhang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):653-5. PubMed ID: 12905700
[TBL] [Abstract][Full Text] [Related]
18. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
[TBL] [Abstract][Full Text] [Related]
19. Reduced expansion of CD94/NKG2C
Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
[TBL] [Abstract][Full Text] [Related]
20. Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence.
Ferron E; David G; Willem C; Legrand N; Salameh P; Anquetil L; Walencik A; Gendzekhadze K; Gagne K; Retière C
Front Immunol; 2024; 15():1389358. PubMed ID: 38736873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
